FindTrial
Sign In

COMPARISON OF POSTOPERATIVE UPPER AIRWAY MORBIDITIES BETWEEN TWO SUPRAGLOTTIC AIRWAY DEVICE IN ADULTS

COMPARISION OF UPPER AIRWAY MORBIDITY BETWEEN THE SUPRAGLOTTIC AIRWAY DEVICES-LMA-PROSEAL AND LMA-I-GEL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013891
Enrollment
66
Registered
2018-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis Health Condition 2: null- POSTOPERATIVE UPPER AIRWAY MORBIDITIES

Interventions

Control Intervention1: LMA I-gel inserted to the arm I: LMA I-gel is an 2nd generation CUFFLESS supraglottic device which is used for intraoperative airway management Control Intervention2: LMA prosea

Sponsors

M S Ramaiah medical college and teaching hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA 1 and 2 physical status grades posted for elective surgery under General anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1) Changes in upper airway complications between 2 groups 2)Postoperative upper airway morbidities like blood staining,sore throat,dysphagia,dysphonia,hoarseness of voice.Timepoint: 1,6,24 hours postoperatively—

Secondary

MeasureTime frame
Changes in Oropharyngeal leak pressures and minute volumeTimepoint: 1,5,10 and 30 minutes after insertion of supraglottic airway device intraoperatively—

Countries

India

Contacts

Public ContactDr Asha Harave Linganna

M S Ramaiah medical college

nagarajmc58@gmail.com9972849779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026